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Abstract
We report the successful fabrication of microelectrode biosensors, onto Pt wires or silicon micro-needles, based on 
oxidase immobilization by poly(ethylene glycol) diglycidyl ether (PEGDE). We found that biosensors made with 
PEGDE exhibited high sensitivity and a response time on the order of seconds. Glucose biosensors implanted in the 
central nervous system of anesthetized rats reliably monitored changes in brain glucose levels induced by sequential 
administration of insulin and glucose. PEGDE provides a simple, low cost, non-toxic alternative for the preparation 
of in vivo microelectrode biosensors. This innovative method was applied to functionalize Pt microelectrodes 
deposited onto silicon microprobes. Their operating parameters were characterized and validated in vivo.
© 2011 Published by Elsevier Ltd.
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1. Introduction
Implantable enzymatic biosensors are widely used for in vivo monitoring applications. They are used in 
neuroscience research to detect neurotransmitters and metabolites with outstanding temporal resolution
[1,2]. These biosensors are usually glass capillary-based platinum microelectrodes constructed according
to a common basic design [3]. However, recent studies are oriented on the development of multisensing 
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probes for simultaneous monitoring of neurotransmitters or metabolites during physiological or 
pathological functioning of the central nervous system (CNS) [4]. Additionally, special attention must be 
paid to the protein immobilization procedure, because it impacts the overall biosensor performance. A
wide variety of enzyme immobilization techniques are now available for biosensor construction. 
However, most methods involve toxic components that make potential clinical applications difficult
[4,5,6]. Moreover, the chemicals used for biosensor preparation are often expensive or imply some 
organic synthesis [7]. Up to now, only few groups succeeded to fabricate multisite probes and applied 
them in vivo [4,5], using highly toxic glutaraldehyde for enzyme immobilization. Overall, there is a need 
for simple, clean and cheap methods for enzyme immobilization on biosensors that could be easily 
reproduced by non-expert laboratories.
In the present study, we investigated the utilization of PEGDE as a matrix for immobilizing 
oxidoreductases on glass capillary biosensors. PEGDE is an essential component of the redox hydrogels 
used for commercial glucose biosensors [8]. However, the interest of using PEGDE alone for 
immobilizing proteins on biosensors has never been thoroughly explored. Here, we firstly examined the 
possibility of several enzymes immobilization onto glass capillary microelectrodes using PEGDE alone. 
The biosensor principal operational parameters were explored and glucose biosensors were validated in 
the CNS of anesthetized rats [9]. Secondly, we produced three-electrode micro-needles by standard 
micromachining process, adapted PEGDE deposition procedure and locally deposited different protein 
layers on each electrode. Biosensors were characterized, cross-talk effects between electrodes were 
measured and finally, they were implanted in the brain of the anesthetized rat for validation in real 
biological conditions.
2. Enzyme immobilization on electrodes by PEGDE.
PEGDE reacts with the amine functional groups present in proteins to create a matrix for enzyme 
immobilization on the electrode surface (Fig. 1). The reaction between the diepoxide and proteins is slow 
at room temperature (~48 h), but can be accelerated considerably by increasing the temperature (8). We 
therefore set the temperature at 55 °C, which is low enough to preserve the activity of all oxidase 
enzymes we tested and 2h incubation of the enzyme/PEGDE mixture was sufficient to achieve 
immobilization in a stable membrane. We tested the PEGDE enzyme immobilization process by 
preparing glucose, D-aminoacid and glutamate oxidase-based biosensors. We studied the dependence of 
biosensor sensitivity on the amount of PEGDE added to the enzyme and showed that the sensitivity of the 
biosensors followed a bell-shaped curve. The optimal PEGDE concentrations for glucose oxidase, DAAO 
and glutamate oxidase were 20 mg/mL, 5.9 mg/mL and 78 mg/mL, respectively in enzyme solutions 
containing 60 mg/mL protein of interest, 30 mg/mL of BSA and glycerol at 1% in 0.01 M PBS. The 
enzyme membrane appeared as a transparent film insoluble in water.
The characteristics of our biosensors were determined and compared with those obtained after 
fixation with glutaraldehyde, one of the most widely used fixative reagents for enzymatic biosensor 
fabrication. The response times of the PEGDE biosensors were similar to those obtained using 
glutaraldehyde. The Km values were generally similar between the two methods. The PEGDE biosensor 
sensitivities were generally higher than those observed with glutaraldehyde fixation [9].
3. In vivo validation
We tested the utility of the PEGDE biosensors in applications requiring in vivo brain implantation. We
implanted glucose biosensors in the frontal cortex of anesthetized rats. Basal brain glucose concentrations
were 0.68 ± 0.15 mM (n = 8). Injection of insulin induced a steady decrease in oxidation current from the
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Fig. 1. General reaction scheme of protein with 
poly(ethylene glycol) diglycidyl ether. All protein 
molecules (enzyme, bovine serum albumin, etc.) 
contain amino- and carboxyl groups that may react 
with the 2 epoxides of PEGDE, resulting in 
immobilization.
Fig. 2. Biosensor recordings in vivo. Glucose monitoring using a 
PEGDE/glucose oxidase biosensor implanted in the frontal cortex of an 
anesthetized rat. Signal detected by a glucose microbiosensor (bold line) 
was compared to that recorded by a control (BSA) biosensor implanted on 
the contra-lateral side of the brain (thin line). 
glucose microbiosensor, but not from the control electrode. Injection of glucose 1 h after insulin 
administration quickly raised the brain glucose signal above its original value (Fig. 2). The extracellular 
brain glucose concentration 1 h after insulin injection was 0.19 ± 0.05 mM, and the concentration rose to 
1.1 ± 0.2 mM after glucose injection [9]. Calibration experiments performed after electrode removal from 
the brain revealed that our biosensors were still functional after in vivo implantation, with some even 
displaying a slight increase in sensitivity. The fact that we could detect glucose changes with our glucose 
oxidase/PEGDE biosensors therefore indicates that our method is well suited for in vivo brain glucose 
monitoring.
4. Biosensor on silicon microneedle.
The microprobes were fabricated starting from 250 μm (100) silicon wafer. The first mask was
transferred to a previously grown thermal oxide (2 μm) to form the needle contour in the front side and 
the second mask was transferred to oxide in the back side to mark further membrane position versus 
needle. The subsequent HF etch of double side oxide was performed. The metallization (20nm Ti and 
150nm Pt) was patterned by a lift-off process using AZ5214 photoresist to design the three-electrode 
probe. Negative SU8- 2000.5 photoresist was used as top passivation. It was opened at the recording sites 
and bonding pads by photoresist development. To determine the needle shape, the first DRIE etch was 
performed on the front side, followed by second one on the back side to define the needle thickness 
(50μm) (Fig. 3). During etching the Pt and SU8 surfaces were protected by photoresist. Finally, the
probes were cut down by diamond saw and packed with custom-made printed circuit boards.
Prior to enzyme immobilization, electrodes were cleaned by cyclic voltammetry treatment in 1M 
H2SO4 solution. Glucose oxidase local deposition onto Pt electrode was achieved with chitosan 
assistance. Chitosan is natural sugar-based polymer, soluble at acid pH and insoluble in neutral solution. 
Application of a negative potential (-1.3 V) to the working electrode provokes chitosan precipitation onto 
electrode, accompanied with enzyme and PEGDE entrapment (Fig. 3). Chitosan contains functional 
amine groups in its structure, and PEGDE performs reliable attachment of proteins to the chitosan layer 
while preventing enzyme leaching from the deposited membrane. We showed that enzyme 
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immobilization involving chitosan decreases the sensitivity of biosensor toward its substrate, compared to 
immobilization by PEGDE alone. Finally, we carried out the preliminary tests for monitoring glucose 
concentrations in vivo with silicon micro-needles. The first Pt electrode was modified by Glucose oxidase 
containing layer while two others were covered only with chitosan/PEGDE layer. We obtained 
monitoring profile similar to that recorded by glass capillary-based microbiosensors (Fig. 2). Basal brain 
glucose concentrations, glucose concentrations 1 h after insulin injection and after glucose injection were 
estimated at 0.52mM, 0.18mM and 0.88mM respectively. Obtained glucose concentration values are 
close to those estimated by glass capillary-based biosensors. These results show that amperometric 
biosensors prepared with oxidases immobilized onto silicon micro-needles using PEGDE can reliably 
monitor the extracellular glucose concentration in the CNS of laboratory animals.
Fig. 3. SEM image of a micromachined silicon microneedle with 3 Pt electrodes. Insert shows enzyme immobilization on the Pt 
electrodes by PEGDE with chitosan-assisted local deposition.
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